This document discusses immunoglobulins (antibodies), including their five classes (IgG, IgM, IgA, IgE, IgD), structure, functions, and production. The key points are: - Immunoglobulins are Y-shaped glycoproteins produced by plasma cells that recognize and bind to specific antigens. They have two heavy chains and two light chains. - The five classes of immunoglobulins are IgG, IgM, IgA, IgE, and IgD, which have different structures, functions, and roles in the immune response. - IgG is the most abundant immunoglobulin and provides long-term protection against pathogens. IgM is the first

1. IMMUNOGLOBULIN
( Antibody)
Presenter : Dr. Dhileeban Maharajan
Moderator : Prof. Biplab Singh

2. ANTIBODIES
 React specifically with the antigen that stimulated their production
 Globulins : alpha, beta & gamma (immunoglobulin)
 “first line of defence”
 Synthesized only by B cell lineage
 Mediators of humoral immunity
 Two types: Membrane bound, Secreted
 Extremely diverse & Specific

3. FUNCTIONS
1. Neutralization of microbial toxins
2. Activation of complement system
3. Opsonization of pathogens  Enhanced phagocytosis
4. Antibody dependent cell mediated cytotoxicity
5. Antibody mediated mast cell activation

4. IMMUNOGLOBULINS
Five classes of immunoglobulins:
i. Immunoglobulin G (IgG)
ii. Immunoglobulin M (IgM)
iii. Immunoglobulin A (IgA)
iv. Immunoglobulin E (IgE)
v. Immunoglobulin D (IgD)

5. Classes of immunoglobulins and their
heavy chains and subclasses
CLASS HEAVY CHAIN SUBCLASSES
IgG Gamma (γ) γ1,γ2,γ3,γ4
IgM Mu (µ) None
IgA Alpha (α) α1,α2
IgD Delta (δ) None
IgE Epsilon (ε) None

6. STRUCTURE OF IMMUNOGLOBULINs
 Glycoproteins & complex structure of four
polypeptide chains
 Two identical heavy chains (typically
50,000–70,000 Da each & longer)
 Two identical light chains (25,000Da each
& shorter)
 This gives immunoglobulin an overall ‘Y’
or ‘T’ shape
 Crystallographic analyses

7. PARATOPE
 Antigen-binding site
 Part of antibody which recognizes and binds to
an antigen (Epitope).
 Small region (5 to 10 amino acids) of the
Variable region (Fab region)
 Contains parts of the heavy and light chains

8. Heavy chain
 Made up of 420–440 amino acids
 Held together by one to five disulfide (S—S) bonds
 Bound to a light chain by disulfide bond & noncovalent bonds
 These interactions form the basic four-chain (H–L)2 antibody structure

9. Light chains
 Made up of 220–240 amino acids
 Structurally and chemically similar in all classes
 2 types: kappa (κ) and lambda (λ)
 They differ in their amino acids present in constant region
 Present in human serum in a ratio of 2:1

10. Variable region
 Amino-terminal half of the light or heavy chain
 Consisting of 100–110 amino acids
 Different for each class of Igs
 The variable regions of both light and heavy chains consist of three
highly variable regions known as hypervariable regions
 Function  Antigen binding site

11. Constant region
 The carboxyl-terminal half of the molecule
 Contains two basic amino acid sequences
 The Fc fragment, found to crystallize under low ionic conditions, is
present in the constant region of heavy chain
 Functions  Activation of the complement, binding to cell surface
receptors, placental transfer, etc.
 The constant region of the light chain has no biological function.

12. Hinge region
 Flexible amino acid stretch
 Present between heavy chains linked by disulfide bonds
 High content of proline and hydrophobic residues
 Flexibility assists inititiation of the complement cascade
 Gamma, delta and alpha chains have hinge region
 Mu and epsilon chains do not have hinge region

13. Papain Cleavage
Papain cleaves just above the interchain disulfide bonds linking the
heavy chains, resulting in production of two identical Fab fragments
(monovalently binds to the antigen) and one Fc fragment

14. Pepsin Cleavage
Pepsin cleaves just below these bonds, thereby generating different
digestion products producing an Fc fragment and two Fab fragments
[F(ab)2], which upon exposure to reducing conditions are separated into
Fab monomeric units

15. Antigen determinants
• 3 major determinants:
– Isotypes
– Allotypes
– Idiotypes

16. Isotypes
 A particular constant region of the light-or heavy-chain of the Ig which is
used to classify them
 present in all members of a species
 Heavy chain isotype markers: µ,γ,α,δ and ε for IgM, IgG, IgA, IgD, and
IgE, respectively
 Light chain isotype markers: κ and λ

17. Allotypes
 Allelic differences in both the variable and constant regions of
immunoglobulin
 Am on α heavy chains, Gm on γ heavy chains, and Km on κ light chains
 >25 Gm types ,3 Km and 2 Am on IgA have been described
 Allotype markers are absent on µ, δ, ε heavy chains and on λ light chains

18. Idiotypes
 A specificity that is associated with the variable region
 Idiotype markers are found on the hypervariable region of the Ig
 Idiotypes are specific for each antibody molecule
 Anti-idiotypic antibodies produced against Fab fragments prevent
antigen–antibody interaction

19. Biosynthesis of Immunoglobulins
• B lymphocytes and plasma cells take part in the synthesis of immunoglobulins
• Resting B cells synthesize only small amounts of Igs that mainly get incorporated
into cell membranes but plasma cells (abundant cytoplasm & rich in ER) produce
and secrete large amounts of immunoglobulins
• In separate polyribosomes, the heavy chain & light chains are produced and later
joined either as H-L hemimolecule or as H2 & L2, Later they associate to form
complete molecule

20. NUCLEUS
ER
POLYRIBOSOMES HEAVY CHAINS
PLASMA CELL
GLYCOSYLATION

21. Immunoglobulin G
 Molecular weight of 150,000 Da
 half-life of 23 days (longest among all the Igs)
 most abundant - about 80% of the total serum immunoglobulin
 Four IgG subclasses based on γ chain isotypes : IgG1, IgG2, IgG3, and IgG4
o IgG1, IgG3 & IgG4: cross placental barrier
o IgG3, IgG1 & IgG2: complement activation
o IgG1 & IgG3: mediate opsonisation (high affinity for Fc receptors of phagocytes)

22. Biological activity
 In response to infection, IgG antibodies appear late after appearance of
IgM antibodies, but persists for a longer period
 Protection against the microorganisms
 Distributed equally in the intra and extra- vascular compartments
 Only Ig that crosses the placenta & confers natural passive immunity to
the newborns
 Takes part in precipitation, complement fixation & neutralization of
toxins and viruses and binds to microorganisms and facilitates the
process of phagocytosis

24. Immunoglobulin M
 Constitute about 5–8% of total serum Ig
 Intra-vascular distribution
 Heavy molecule with molecular weight varying from 900k to 1,000k Da
 Half-life of 5 days
 basically a pentamer, composed of five Ig subunits & J-chain
 2 µ heavy chains & 2 κ/λ light chain
 Heavy chains are larger than those of IgG by about 20,000 Da,
corresponding to an extra domain on the constant region

26. Biological activities
 Pentameric IgM has high valency (10 antigen binding sites) thus efficient
in binding antigens with many repeating epitopes, such as viral particles
and RBCs
 Efficient than IgG in activating complement
 Good complement activation (two Fc regions in close proximity)
 First Ig produced in primary response; deficiency leads to septicaemia
 Also act as a B cell receptor

27.  Presence of IgM antibody in serum indicates recent infection (short lived
and disappear early)
 First Ig to be synthesized by a neonate in about 20 weeks of age; since it
is not able to cross placenta, its presence indicates intra-uterine infection
 The detection of IgM antibodies in serum is useful for the diagnosis of congenital
infections, such as syphilis, rubella, toxoplasmosis, etc.

28. Immunoglobulin A
 2nd most abundant Ig (10–15% of serum IG)
 Half-life of 6–8 days
 Consists of α heavy chain (58-kDa & 470 amino acid residue) with 3
constant domains CH1, CH2, and CH3 and 1 variable domain VH
 Hinge region is situated between CH1 and CH2 domains
 An additional segment of 18-AA residues at the penultimate position of
the chain contains a cysteine residue where the J chain can be attached
through a disulfide bond.

30.  IgA occurs in two forms: Serum IgA and Secretory IgA
Serum IgA
 molecular weight of 60kDa & 1/2 life 6-8 days
 two subclasses, IgA1 and IgA2 (two α chain isotypes α1 and α2)
 α2 chain has two allotypes, A2m (1) and A2m (2), and does not have
disulfide bonds linking heavy to light chains
 Differences in the two α chains are found in two CH1 and five CH3
positions & hence there are three varieties of α heavy chains in humans

31. Secretory IgA
 Dimer or tetramer and consists of a J-chain polypeptide and a polypeptide
chain called secretory component (70kDa & produced by mucous membrane
epithelial cells)
 Has 5 Ig-like domains that bind to
the Fc region domains of the IgA dimer
 This interaction is stabilized by a disulfide
bond between the fifth domain and one
of the chains of dimeric IgA

32.  IgA-secreting plasma cells are concentrated along mucous membrane
surfaces
 The daily production of secretory IgA is greater than that of any other Igs
 Secretory IgA is the major Ig present in external secretions, such as
breast milk, saliva, tears & mucus of the bronchial, genitourinary, and
digestive tracts
 IgA activates the complement not by classical pathway but by alternative
pathway

34. Biological functions of secretory IgA
 It is polymeric & hence can cross-link large antigens with multiple
epitopes thus protects the mucous membranes against microbial
pathogens
 Binding of secretory IgA to bacterial and viral surface antigens prevents
attachment of the pathogens to the mucosal cells thus inhibiting
colonization.

35.  Complexes of secretory IgA and antigen are easily entrapped in mucus
and then eliminated by the ciliated epithelial cells of the respiratory tract
or by peristalsis of the gut
 IgA in breast milk protect the newborns against infection during the first
month of life
 Secretory IgA has shown to provide an important line of defense against
bacteria (such as Salmonella, Vibrio cholerae, and Neisseria ) and viruses
(such as polio, influenza, and reovirus)

36. Immunoglobin E
 IgE constitutes less than 1% of the total Ig pool
 Present in serum in a very low concentration (0.3 g/mL) & mostly found
extravascularly in lining of respiratory and intestinal tracts
 MW of 190K Da & ½ life of 2–3 days
 Unlike other Igs, IgE is a heat-labile protein, easily inactivated at 56°C in 1
hour
 Two ε heavy polypeptide chains (72-kDa, 550- AA residue), along with
two κ or two λ light chain, together by disulfide bonds

38. Biological activity
 Reaginic antibody mediates the type I immediate HS (atopy) reactions
 Responsible for the symptoms of hay fever, asthma & anaphylactic
shock
 IgE binds to Fc receptors on the membranes of blood basophils and
tissue mast cells & antigen (allergen) induces basophils and mast cells to
translocate their granules to the plasma membrane and release their
contents to the extracellular environment - a process known as
degranulation

39.  As a result, varieties of pharmacologically active mediators are released and
give rise to allergic manifestations
 Localized mast-cell degranulation necessary for antiparasitic defence

40. Immunoglobulin D
 IgD comprises less than 1% of serum Ig(MW 180k Da & half-life of only 2–3 days)
 IgD has basic four chain monomeric structure with two δ heavy chains (MW
63kDa each, 500-amino acid residue) and either two κ or two λ light chains(MW
22kDa each)
 The δ heavy polypeptide chain consisting of one variable region VH, and a three-
domain constant regions CH1, CH2, and CH3
 IgD is present on the surface of B lymphocytes and both IgD & IgM serve as
recognition receptors for antigens

43. Role of immunoglobulins in human
defence
IgG IgM IgA IgD IgE
Enhances
phagocytosis
Especially
effective against
microbes &
agglutinating
antigens
Localized
protection
on mucosal
surfaces
Serum
function not
known
Allergic
reaction
Neutralizes
toxins and
viruses
First antibody
produced in
response to
initial infection
-
Present on B
cells; and
function
in initiation
of immune
response
Lysis of
parasitic
worms
Protects fetus
and newborn

44. Abnormal immunoglobulins
 Structurally similar proteins that are found in serum in certain
pathological conditions
– multiple myeloma,
– heavy chain disease
– cryoglobulinemia
– Rarely in healthy individuals

45. Multiple myeloma
 This condition is characterized by excessive production of the respective
myeloma proteins (M proteins) and that of their light chains (BJ proteins)
 Bence-Jones (BJ) proteins -- earliest abnormal proteins
 BJ proteins are the light chains of Igs, hence occur as either κ or λ forms
 BJ proteins have a peculiar property of coagulating at 60°C and
redissolving again at a higher temperature of 80°C

46.  They remained the major source of homogeneous Igs until the
development of the hybridoma in 1974
 In multiple myeloma, plasma cells synthesizing IgG, IgA, IgD or IgE are
affected
 Myeloma involving IgM-producing plasma cells is known as
Waldenström’s macroglobulinemia
Heavy chain disease:
 Lymphoid neoplasia, characterized by an excess production of heavy
chains of the immunoglobulins

47. Cryoglobulinemia
 Condition characterized by presence of cryoglobulins in blood
 The condition may not be always associated with disease but is often
found in patients with macroglobulinemia, SLE or myelomas
 Most cryoglobulins consist of either IgG or IgM or their mixed
precipitates & serum from patient precipitates on cooling and
redissolves on warming.

48. Immunoglobulin as Medicine
Immunosuppressive Antibodies
 Hybridoma Technology
 Milstein and Kohler – 1974
 HAMA – Human anti-mouse antibodies

49. Intravenous Immune Globulin (IVIG)
• Polyclonal human Immunoglobulin
• Thousands of healthy donors
• Not specific against single antigen
• Normalizing effect in immune network
• High Dose IVIG – 2gm/kg use:
– ITP
– Kawasaki’s disease
– GBS

50. Replacement therapy
(Low dose therapy)
Immunomodulatory effect
(High dose therapy)
Licensed Off-label
•Primary immunodeficiency
•HIV infection
•BMT
•B-cell lymphocytic leukemia
•Multiple myeloma
•Immune
thrombocytopenic
purpura
•GBS
•CIDP
•Kawasaki disease
•Multifocal motor
neuropathy
•Autoimmune neutropenia
•Autoimmune hemolysis
•Anti Factor VIII inhibitor
•Multiple sclerosis
•Myasthenia gravis
•Stiff person syndrome
•ANCA associated vasculitis
•Polymyositis/Dermatomyositis
•RA
•SLE – APS
•GVHD
•Sepsis syndrome
•TEN
•Graves opthalmopathy

51. Hyperimmune Immunoglobulins
• Selected donor with high titers of antibodies against
particular agents
• To reduce the severity of infection
• Use:
– Respiratory syncytial virus
– CMV
– Varicella zoster
-- HHV 3
-- Hepatitis B virus
-- Tetanus
-- As anti-venom

53. Monoclonal Antibodies

54. Thank You